Kusajili – Clinical trials directory

Result of your search per sponsor: Institut Produits Synthèse (IPSEN) AB

Woman and Man Max 99 years
Institut Produits Synthèse (IPSEN) AB Update Il y a 4 ans

A PHASE IV, OPEN-LABEL, RANDOMISED, CROSS-OVER STUDY TO ASSESS PATIENT PREFERENCE AND HEALTH ECONOMY IN PATIENTS WITH NEUROENDOCRINE TUMOURS, TREATED WITH LANREOTIDE AUTOGEL GIVEN AS SELF ADMINISTRATION To assess the patient preference of two lanreotide Autogel administration practices; self/partner or healthcare professional administration.

Country None
organs None
Specialty None

Closed trial

More information